Lactobacillus Delbrueckii

OTHER NAME(S): L. bulgaricus, L. delbrueckii, Lactobacillus bulgaricus, Lactobacillus delbrueckii, Lactobacillus delbrueckii subsp. lactis

Overview

Lactobacillus delbrueckii (L. delbrueckii) is a probiotic bacteria that is available over the counter as a supplement and in some fermented foods. It is commonly used to improve the health of the brain and gut, but its benefits are not well defined. Common side effects include gas and an upset stomach. Serious side effects are rare but include infections in some people who are at high risk for infections. Before taking L. delbrueckii, make sure to tell your health care provider about any health conditions you have or medicines you are taking.

References
  1. Age: “Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.”
  2. BMC Research Notes: “Fermented soy supplementation improves indicators of quality of life: A randomized, placebo-controlled, double-blind trial in adults experiencing heartburn.”
  3. British Journal of Nutrition: “Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1.”
  4. Food Science & Nutrition: “Lactobacillus delbrueckii: a functional powerhouse in dairy fermentation and emerging probiotic applications.”
  5. Frontiers in Gastroenterology: “A systematic review and meta-analysis of Lactobacillus acidophilus and Lactobacillus bulgaricus for the treatment of diarrhea.”
  6. National Center for Complementary and Integrative Health: “5 Things To Know About Probiotics,” “Probiotics: Usefulness and Safety.”
  7. National Institutes of Health Office of Dietary Supplements: “Probiotics Fact Sheet for Consumers,” “Probiotics Fact Sheet for Health Professionals.”
  8. Nutrients: “Anti-fatigue effects of yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 in healthy people suffering from summer heat fatigue: A randomized, double-blind, placebo-controlled trial,” “Efficacy and safety of Lactobacillus delbrueckii subsp. lactis CKDB001 supplementation on cognitive function in mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial.”
  9. FDA: “FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants.”